Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

OBJECTIVE: The aim of this study was to assess long-term golimumab therapy in patients with rheumatoid arthritis (RA) who discontinued previous tumour necrosis factor alpha (TNFα) inhibitor(s) for any reason. METHODS: Results through week 24 of this multicentre, randomised, double-blind, placebo-con...

Descripción completa

Detalles Bibliográficos
Autores principales: Smolen, Josef S, Kay, Jonathan, Landewé, Robert B M, Matteson, Eric L, Gaylis, Norman, Wollenhaupt, Jurgen, Murphy, Frederick T, Zhou, Yiying, Hsia, Elizabeth C, Doyle, Mittie K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439650/
https://www.ncbi.nlm.nih.gov/pubmed/22459542
http://dx.doi.org/10.1136/annrheumdis-2011-200956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439650/
https://www.ncbi.nlm.nih.gov/pubmed/22459542
http://dx.doi.org/10.1136/annrheumdis-2011-200956

Ejemplares similares